Location History:
- Walnut Creek, CA (US) (2010 - 2014)
- Poway, CA (US) (2018 - 2019)
- San Diego, CA (US) (2021)
- Power, CA (US) (2022)
Company Filing History:
Years Active: 2010-2022
Title: Mark A Bernard: Innovator in Nucleic Acid Sequencing
Introduction
Mark A Bernard is a prominent inventor based in Poway, California, known for his significant contributions to the field of nucleic acid sequencing. With a total of five patents to his name, Bernard has made remarkable advancements in the methods and systems used for sequencing nucleic acids. His work has the potential to enhance the accuracy and efficiency of genetic analysis.
Latest Patents
Bernard's latest patents include innovative methods for nucleic acid sequencing. One of his notable inventions is a method that provides compositions, methods, and systems for sequencing a template nucleic acid using a polymerase-based, nucleic acid binding reaction. This method involves examining the interaction between a polymerase and template nucleic acid in the presence of unlabeled nucleotides. The approach allows for the identification of a base of a template nucleic acid during synthesis by controlling the sequencing reaction conditions.
Another significant patent focuses on a method and system for sequencing nucleic acids through a polymerase-based, sequencing-by-binding procedure. This method includes an examination step that monitors the interaction between a polymerase and template nucleic acid, determining the identity of the next correct nucleotide without incorporating any nucleotide into the primer structure. This innovative sequencing-by-binding procedure does not require labeled nucleotides or polymerases, although these reagents can be optionally employed.
Career Highlights
Throughout his career, Mark A Bernard has worked with notable companies in the biotechnology sector, including Omniome, Inc. and Pacific Biosciences of California, Inc. His experience in these organizations has contributed to his expertise in nucleic acid sequencing technologies.
Collaborations
Bernard has collaborated with esteemed colleagues such as Kandaswamy Vijayan and Eugene Tu, further enhancing the impact of his work in the field of genetic research.
Conclusion
Mark A Bernard's innovative contributions to nucleic acid sequencing have positioned him as a key figure in biotechnology. His patents reflect a commitment to advancing genetic analysis techniques, which may lead to significant breakthroughs in various scientific applications.